Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sumitomo Chemical Co ( (JP:4005) ) has shared an announcement.
Sumitomo Chemical Co., Ltd. announced significant impairment losses and finance expenses for the fourth quarter of FY2024. The impairment losses, totaling ¥20,802 million, were primarily due to decreased profitability in their advanced medical solutions and essential materials sectors, as well as the devaluation of patent rights. Additionally, a foreign exchange loss of ¥26,342 million was recorded, impacting the company’s financial results due to fluctuations in foreign currency valuations.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen370.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co., Ltd. operates in the chemical industry, focusing on producing fine chemicals, advanced medical solutions, and essential & green materials. The company is involved in various sectors, including pharmaceuticals and materials production, with a market focus on innovative solutions and sustainability.
Average Trading Volume: 11,267,398
Technical Sentiment Signal: Sell
Current Market Cap: Yen587.4B
For detailed information about 4005 stock, go to TipRanks’ Stock Analysis page.